Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials

BACKGROUND: The CAIRO3 and AIO 0207 trials demonstrated the efficacy of fluoropyrimidine plus bevacizumab (FP+Bev) maintenance treatment in metastatic colorectal cancer (mCRC) patients. In this individual patient data meta-analysis with updated follow-up, we aim to provide more precise estimates of...

Descripción completa

Detalles Bibliográficos
Autores principales: Goey, Kaitlyn K H, Elias, Sjoerd G, Hinke, Axel, van Oijen, Martijn G H, Punt, Cornelis J A, Hegewisch-Becker, Susanna, Arnold, Dirk, Koopman, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729483/
https://www.ncbi.nlm.nih.gov/pubmed/29123255
http://dx.doi.org/10.1038/bjc.2017.382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729483/
https://www.ncbi.nlm.nih.gov/pubmed/29123255
http://dx.doi.org/10.1038/bjc.2017.382

Ejemplares similares